Chongqing Zhifei Biological Products Co., Ltd. (300122.SZ)
CNY 27.93
(-0.78%)
CNY 27.93
(-0.78%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 8.99 Billion | 1.98 Billion | 8.5 Billion | 3.49 Billion | 1.36 Billion | 585.59 Million |
| Net Income | 8.06 Billion | 7.53 Billion | 10.2 Billion | 3.3 Billion | 2.36 Billion | 1.45 Billion |
| Depreciation & Amortization | 338.38 Million | 314.94 Million | 375.84 Million | 120.93 Million | 88.51 Million | 84.93 Million |
| Deferred income taxes | -385.92 Million | -58.3 Million | 27.27 Million | -44.52 Million | -2.2 Million | -13.71 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 268.19 Million | -6.46 Billion | -2.43 Billion | -203.45 Million | -1.25 Billion | -1.05 Billion |
| Other non-cash items | 1.11 Billion | 602.9 Million | 359.89 Million | 277.88 Million | 170.26 Million | 107.92 Million |
| Investing Cash Flow | -976.59 Million | -1.49 Billion | -2.01 Billion | -896.88 Million | -622.73 Million | -493.13 Million |
| Investments in PPE | -1.13 Billion | -1.45 Billion | -1.93 Billion | -826.98 Million | -572.93 Million | -479.82 Million |
| Acquisitions | 168.07 Million | 646.78 Thousand | 324.99 Thousand | 101.09 Thousand | 197.85 Thousand | 688.87 Thousand |
| Investment purchases | -10.5 Million | -45.5 Million | -69 Million | -70 Million | -50 Million | -14 Million |
| Sales/Maturities of investments | - | -646.78 Thousand | 1.46 Million | -101.09 Thousand | -197.85 Thousand | 607 Million |
| Other Investing Activities | 157.57 Million | 646.78 Thousand | -20.02 Million | 101.09 Thousand | 197.85 Thousand | 688.87 Thousand |
| Financing Cash Flow | -4.29 Billion | -2.17 Billion | -3.58 Billion | -2.11 Billion | -392.79 Million | -288.42 Million |
| Debt repayment | -3.39 Billion | -6.64 Billion | -5.31 Billion | -8.03 Billion | -2.81 Billion | -789.89 Million |
| Dividends payments | -800 Million | -960 Million | -800 Million | -800 Million | -800 Million | -234.12 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -97.21 Million | 5.48 Billion | 2.58 Billion | 6.84 Billion | 3.29 Billion | 735.59 Million |
| Accounts receivables | -6.75 Billion | -8.05 Billion | -6.54 Billion | -2.24 Billion | -2.53 Billion | -1.34 Billion |
| Accounts payables | 8.33 Billion | 2.41 Billion | 8.06 Billion | 3.06 Billion | 2 Billion | 1.47 Billion |
| Inventory | -1.31 Billion | -765.6 Million | -3.98 Billion | -974.8 Million | -729.83 Million | -1.16 Billion |
| Other working capital | 7.95 Billion | -58.3 Million | 27.27 Million | -44.52 Million | -2.2 Million | 110.31 Million |
| Cash at beginning of period | 2.62 Billion | 4.27 Billion | 1.39 Billion | 909.72 Million | 557.41 Million | 751.2 Million |
| Cash at end of period | 6.34 Billion | 2.61 Billion | 4.27 Billion | 1.39 Billion | 909.72 Million | 557.41 Million |
| Capital Expenditure | -1.13 Billion | -1.45 Billion | -1.93 Billion | -826.98 Million | -572.93 Million | -479.82 Million |
| Effect of forex changes on cash | -2.3 Million | 17.55 Million | -9.66 Million | -4.92 Million | 850.96 Thousand | 2.17 Million |
| Net cash flow / Change in cash | 3.71 Billion | -1.66 Billion | 2.88 Billion | 481.29 Million | 352.31 Million | -193.79 Million |
| Free Cash Flow | 7.86 Billion | 535.93 Million | 6.57 Billion | 2.66 Billion | 794.06 Million | 105.76 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -83.69 Million | 776.57 Million | 1.45 Billion | 8.06 Billion | 1.53 Billion | 2.27 Billion |
| Depreciation & Amortization | - | 100.41 Million | 100.41 Million | 338.38 Million | 85.58 Million | 85.58 Million |
| Deferred income taxes | - | - | - | -385.92 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -5.47 Billion | - | 268.19 Million | -8.06 Billion | - |
| Other non-cash items | -2.67 Billion | 3.18 Billion | -5.73 Billion | 1.11 Billion | 4.95 Billion | -1.86 Billion |
| Investing Cash Flow | -272.75 Million | -186.86 Million | -236.2 Million | -976.59 Million | -307.27 Million | -107.52 Million |
| Investments in PPE | -272.76 Million | -193.04 Million | -234.66 Million | -1.13 Billion | -314.47 Million | -269.55 Million |
| Acquisitions | 14 Thousand | 4.61 Million | 23 Thousand | 168.07 Million | 17.7 Million | 149.61 Million |
| Investment purchases | - | - | - | -10.5 Million | -10.5 Million | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 14 Thousand | 1.56 Million | -1.56 Million | 157.57 Million | 7.2 Million | 12.42 Million |
| Financing Cash Flow | 708.34 Million | -1.16 Billion | 1.14 Billion | -4.29 Billion | -2.66 Billion | -770.76 Million |
| Debt repayment | -2.65 Billion | -1.12 Billion | -1.46 Billion | -3.39 Billion | -2.63 Billion | -3.74 Billion |
| Dividends payments | -1.93 Billion | -35.8 Million | -23.35 Million | -800 Million | -800 Million | -20.31 Million |
| Common Stock Repurchased | 300.03 Million | -300.03 Million | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -3.04 Million | 261.26 Million | -327.13 Million | -97.21 Million | 771.28 Million | 2.99 Billion |
| Accounts receivables | - | 1.2 Billion | - | -6.75 Billion | -6.75 Billion | - |
| Accounts payables | - | - | - | 8.33 Billion | - | - |
| Inventory | - | -6.68 Billion | - | -1.31 Billion | -1.31 Billion | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 5.58 Billion | 2.97 Billion | 6.34 Billion | 2.62 Billion | 2.9 Billion | 3.37 Billion |
| Cash at end of period | 3.26 Billion | 5.58 Billion | 2.97 Billion | 6.34 Billion | 6.34 Billion | 2.89 Billion |
| Capital Expenditure | -272.76 Million | -193.04 Million | -234.66 Million | -1.13 Billion | -314.47 Million | -269.55 Million |
| Effect of forex changes on cash | -1.33 Million | 373.02 Thousand | 161.58 Thousand | -2.3 Million | -1.29 Million | -654.66 Thousand |
| Net cash flow / Change in cash | -2.32 Billion | 2.61 Billion | -3.36 Billion | 3.71 Billion | 3.43 Billion | -470.16 Million |
| Free Cash Flow | -3.03 Billion | 3.77 Billion | -4.5 Billion | 7.86 Billion | 6.09 Billion | 139.23 Million |
PBR-A
1890
JPPHY
1053
601898
ARTO